Risk factors and growth factors in ROP

C Romagnoli1

  • 1Division of Neonatology, Catholic University of Rome, Largo A. Gemelli, 8 00168, Rome, Italy. j.rampazzi@emec-roma.com

Early Human Development
|October 16, 2009
PubMed

Insights

Retinopathy of prematurity (ROP) is a growing concern in very preterm infants. Early intervention is crucial, as risk factors significantly impact retinal vascular development from the first weeks of life.

Area of Science:

  • Ophthalmology
  • Neonatology
  • Developmental Biology

Background:

  • Retinopathy of prematurity (ROP) incidence is rising due to increased survival rates of very preterm infants.
  • ROP involves abnormal retinal vascular development influenced by vascular growth factors like IGF-1 and VEGF.
  • Numerous factors, including gestational age, birth weight, oxygen, infections, and transfusions, affect retinal vascularization.

Purpose of the Study:

  • To analyze the time-dependent role of postnatal risk factors in the pathogenesis of Retinopathy of Prematurity.
  • To determine the critical window for intervention in very preterm infants at risk for ROP.

Main Methods:

  • Review of existing literature on Retinopathy of Prematurity pathogenesis and risk factors.
  • Analysis of the temporal influence of various risk factors on retinal vascular development.
  • Correlation of early-life risk factors with the onset and severity of ROP.

Main Results:

  • Postnatal risk factors significantly influence retinal vascular development in a time-dependent manner.
  • The critical period for ROP pathogenesis is within the first two to four weeks of life.
  • ROP development begins before clinical features are apparent, highlighting the importance of early risk factor management.

Conclusions:

  • Preventive strategies for Retinopathy of Prematurity in very preterm infants must be implemented from birth.
  • Understanding the temporal dynamics of risk factors is essential for effective ROP prevention.
  • Early and continuous monitoring and management of risk factors are vital for improving outcomes in preterm infants.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...